Non-Small Cell Lung Cancer Clinical Trial Results

Browse clinical trials for Non-Small Cell Lung Cancer by phase, sponsor and reported results. Data from ClinicalTrials.gov.

• A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unrese
  Phase 3 · AstraZeneca · Active, not recruiting · Apr 3, 2025
• Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small
  Phase 1/2 · National Cancer Institute (NCI) · Active, not recruiting · Jul 12, 2021
• Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Feb 2, 2021
• Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lun
  Phase 1/2 · National Cancer Institute (NCI) · Active, not recruiting · Jun 19, 2025
• Premedication to Reduce Amivantamab Associated Infusion Related Reactions
  Phase 2 · Janssen Research & Development, LLC · Active, not recruiting · Oct 20, 2025
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Feb 2, 2026
• Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Wit
  Phase 3 · Daiichi Sankyo · Active, not recruiting · Jul 23, 2025
• A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
  Phase 2 · Joseph J. Cullen, MD, FACS · Active, not recruiting · Jul 31, 2026
• Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin
  Phase 1/2 · National Cancer Institute (NCI) · Active, not recruiting · Mar 24, 2026
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metas
  Phase 2 · National Cancer Institute (NCI) · Active, not recruiting · Jun 25, 2024
• Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
  Phase 1/2 · HUYABIO International, LLC. · Completed · Jul 30, 2026
• A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-B
  Phase 3 · Janssen Research & Development, LLC · Active, not recruiting · Apr 16, 2025
• A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amp
  Phase 2 · AstraZeneca · Active, not recruiting · Sep 24, 2024
• ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
  Phase 2 · ETOP IBCSG Partners Foundation · Completed · May 12, 2026
• Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Ther
  Phase 3 · Merck Sharp & Dohme LLC · Active, not recruiting · Sep 19, 2024

Trials by condition

Lung CancerNon-Small Cell Lung CancerBreast CancerColorectal CancerGastric CancerLiver CancerPancreatic CancerProstate CancerOvarian CancerMelanomaLeukemiaLymphomaMultiple MyelomaGlioblastomaType 2 DiabetesObesityHypertensionHeart FailureAtrial FibrillationStrokeChronic Kidney DiseaseNASH / MASHAlzheimer’s DiseaseParkinson’s DiseaseMultiple SclerosisDepressionEpilepsyALSRheumatoid ArthritisPsoriasisAtopic DermatitisCrohn’s DiseaseUlcerative ColitisLupusAsthmaCOPD

All trials